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another with IMRT. The original plans delivered to the 
patients were not considered in this study because treatment 
techniques have been changing since 2000 and were not 
uniform within the selected group. All plans assured PTV 
coverage according to ICRU 83 criteria. Cochleas and 
supratentorial brain mean doses, as organs , were analyzed 
using QUANTEC values and compared for each plan. 
 
Results: Among 29 children, 22 were males. The median age 
at diagnosis was 8.66 years. At the beginning of treatment, 
their age range from 3.26 to 15.47 years old. The average 
mean dosesto the OAR analyzed are presented in Table 1. 
Table 1: Average Mean Doses to OARs 
 
 
 
Conclusion: The plans for the CRT technique, with 2 parallel 
opposed fields, produced worst results for both OARs. The 
IMRT technique was slightly superior to the 3D-CRT in terms 
of mean dose of cochleas but conducted, in average, to 
higher dose values to the supratentorial brain. Based on 
these results we decided to adopt the 3D-CRT technique for 
the boost phase in high-risk group and IMRT for the standard-
risk group, considering the higher potencial impact in the 
cochleas mean doses in this risk-group.  
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Purpose or Objective: This work is to present the treatment 
planning workflow and delivery technique for the first 
application of linac based spatially fractionated mini-beam 
radiotherapy within a clinical trial of canine brain tumor 
treatments. The motivation for this investigation originates 
from work performed using synchrotron generated micro-
beams (MRT) which have shown promising results in 
preserving brain architecture while killing tumor cells. 
Spatial fractionation of radiation using arrays of parallel 
micro-planar beams is a developing technique with many 
unknowns and limitations. To further research this technique 
and to potentially enable MRT for human treatments, a mini-
beam collimator has been designed for use with a linac and a 
Monte Carlo (MC) beam model has been commissioned for 
clinical treatment planning. 
 
Material and Methods: Patient population was selected from 
client-owned canines with spontaneously occurring brain 
tumors. Patients were placed under general anesthesia and 
positioned prone within stereotactic immobilization 
equipment during imaging and treatment delivery. CT and 
MRI images were used for contouring. The planning technique 
utilized an arrangements of static mini-beams. Beam angles 
were chosen such that the treatment depth was within 20% 
for each beam to minimize beam broadening with depth and 
blurring of the peak and valley doses. Beam apertures were 
defined with the MLC leaves set 3 mm back from the PTV. 
The mini-beam collimated dose distributions were calculated 
to a statistical uncertainty of ±1.0 % within a voxel size of 0.5 
mm. Beam weighting was equalized and the plan normalized 
such that the prescription dose was delivered to an ICRU dose 
reference point within the PTV. Deliver quality assurance 
(DQA) was performed by measuring the absolute dose from 
each beam using an ion chamber within a solid water 
phantom. 
 
Results: Contouring and beam arrangement, which included 
MLC placement, was performed within the clinical treatment 
planning system (TPS). The DICOM plan was then exported to 
the MC treatment planning system for mini-beam dose 
calculation. The distribution was reviewed and DVHs assessed 
for normal tissue tolerances. The final step was to transcribe 
the calculated MUs back to the original TPS. Planning 
turnaround time was 2 days. The MC calculations were 
initiated overnight at the end of day 1. Day 2 was spent 
reviewing the plan, generating the DQA plan, and finalizing 
the treatment parameters into the record-and-verify system 
(RVS). DQA output measurements of the treatment fields 
agreed with the calculated dose to within 1.5%. An image of 
the patient dose distribution and setup is shown in figure 1. 
 
 
Conclusion: A workflow for mini-beam treatments that 
includes the planning technique, MC dose calculation 
method, DQA process, and data integration into a RVS has 
been established. This clinical dataset represents the first 
treatment planning study of linac based mini-beam patients. 
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Purpose or Objective: The aim of this study is to investigates 
different strategies in choosing, in a mathematical way, the 
structure set that best fit a Dose Painting (DP) distribution, 
based on ADC maps, to be submitted to the optimization 
process within the TomoTherapy TPS. 
 
Material and Methods: Hypofractionated Stereotactic 
Radiation Therapy plans in 5 fractions of intracranial GBM for 
six patients were retrospectively realized. 
